⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025
accessnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
prnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
MLTX
Investors Urged to Contact Levi & Korsinsky for Information Before December 15, 2025 - MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Pomerantz LLP Highlights Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
MLTX
MLTX LAWSUIT NOTICE: MoonLake Immunotherapeutics Faces Securities Fraud Class Action Due to Drug Trial Results - Contact BFA Law if You Suffered Losses
accessnewswire.com
MLTX
MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors - Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX
prnewswire.com
MLTX
SueWallSt Podcast Series Launches With Focus on MoonLake Immunotherapeutics (MLTX) Fraud Allegations
accessnewswire.com
MLTX